AR and esophageal adenocarcinoma: The expression of the androgen receptor (AR) in OC is noteworthy, as studies have indicated a reduction in the occurrence of esophageal squamous carcinoma (ESCC) and esophageal adenocarcinoma (EAC) subsequent to androgen deprivation therapy (39).